Project/Area Number |
23H02104
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Review Section |
Basic Section 37030:Chemical biology-related
|
Research Institution | University of Toyama |
Principal Investigator |
Suresh Awale 富山大学, 学術研究部薬学・和漢系, 准教授 (00377243)
|
Co-Investigator(Kenkyū-buntansha) |
藤井 努 富山大学, 学術研究部医学系, 教授 (60566967)
|
Project Period (FY) |
2023-04-01 – 2028-03-31
|
Project Status |
Granted (Fiscal Year 2023)
|
Budget Amount *help |
¥18,590,000 (Direct Cost: ¥14,300,000、Indirect Cost: ¥4,290,000)
Fiscal Year 2023: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
|
Keywords | Pancreatic canecer / antiausterity / napthylisoquinolines / anti tumor agents / in vivo |
Outline of Research at the Start |
This project aimed to investigate naphthylisoquinoline alkaloids as new anti-tumor chemotherapeutic agents and provide strong preclinical evidence for drug development against pancreatic cancer through in vivo xenograft tests.
|